LONDON (Alliance News) - The following is a summary of top news stories Friday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />Biopharmaceutical company <strong>Shire</strong> PLC saw its shares fall Friday after it said late Thursday it would abandon clinical development Read More
(Correcting name of European Court of Justice.) LONDON (Alliance News) - The UK's main stock indices are modestly higher Friday, holding on to small morning gains but losing Thursday's momentum amid mixed UK economic data and ahead of the key US jobs report still to come this afternoon. Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Tate & Lyle, up 2.2%. The speciality food and bulk ingredients manufacturer has jumped after JPMorgan Cazenove upgraded its r Read More
LONDON (Alliance News) - The UK's main stock indices are modestly higher Friday, holding on to small morning gains but losing Thursday's momentum amid mixed UK economic data and ahead of the key US jobs report still to come this afternoon. By mid-morning Friday, the FTSE 100 is up 0.2% at 6 Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />S&P CAPITAL IQ RAISES ASTRAZENECA PRICE TARGET TO 3800 (3700) PENCE - 'HOLD' <br />----------<br />SO Read More
LONDON (Alliance News) - Biopharmaceutical company Shire PLC Friday saw its shares fall after it said it would abandon clinical development of Vyvanse for the potential treatment of major depressive disorder after it failed late-stage trials. In a statement, the company said that two pivota Read More
LONDON (Alliance News) - UK shares have opened higher Friday, as the market looks ahead positively to the US non-farm payrolls report later in the day.<br /><br />After its results on Thursday, <strong>AstraZeneca</strong> has been named a Conviction Buy by Liberum. Meanwhile, JPMorgan has lif Read More
SAINT HELIER (Alliance News) - Shire PLC said Thursday that two pivotal Phase 3 investigational studies evaluating the efficacy and safety of Vyvanse Capsules versus placebo as an adjunctive treatment for major depressive disorder in adults who inadequately responded to antidepressant monotherapy Read More
LONDON (Alliance News) - AstraZeneca PLC lowered its full-year forecast Thursday, as it saw revenue and pretax profit decline in the full year ended December 31, 2013, due to the loss of exclusivity on several of its brands and increased competition from generics. The pharmaceutical giant p Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />BARCLAYS RAISES LONDON STOCK EXCHANGE PRICE TARGET TO 2200 (1800) PENCE - 'OVERWEIGHT' <br />----------<br />NUMIS RAISES LONDON Read More
LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.<br /><br />In a speech at the World Ec Read More
LONDON (Alliance News) - Shire PLC said Friday that it had completed its tender off for the US's ViroPharma Inc, with 79.5% valid acceptances. The pharmaceutical company said it expects to complete the merger of ViroPharma with one of its subsidiaries later Friday, and following this merger Read More
LONDON (Alliance News) - Publisher Pearson is the biggest faller on the FTSE 100 Thursday after it issued a profit warning, saying trading had been weaker than it expected, particularly in North America, its main market. The Financial Times owner and publisher of education books said it had Read More
LONDON (Alliance News) - Biopharmaceutical company Shire PLC Thursday named Susan Kilsby as its new non-executive chairman. Kilsby will be replacing Matthew Emmens who is retiring, after more than 10 years with Shire. Kilsby joined the FTSE 100 company's board as a non-executive direc Read More
LONDON (Alliance News) - Shares have opened lower Thursday following disappointing PMI figures from China. Financial and education publisher <strong>Pearson</strong> is down 5.9% at the open after saying its 2013 performance was weaker than expected, particularly in North America.<br />< Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning and Friday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />CREDIT SUISSE RAISES NEXT PRICE TARGET TO 6500 (5500) PENCE - 'NEUTRAL' <br />----------<br />BERENBERG RAI Read More
LONDON (Alliance News) - Shire PLC said Friday that it had sold its Dermagraft living skin substitute assets to the US's Organogenesis Ltd, as it said the prospects of the product had been "significantly" reduced, and will take a USD650 million loss on the disposal. Massachusetts-based Orga Read More
LONDON (Alliance News) - Oil giant <strong>Royal Dutch Shell</strong> shocked the market Friday by warning that its profits will be well below expectations after nearly every part of its business performed below its expectations in the fourth quarter.<br /><br />The profit warning has sent its Read More